MMP-13 Substrate is a designed peptide incorporating recognition residues tailored for matrix metalloproteinase cleavage. Researchers use it to monitor catalytic turnover, specificity signatures, and kinetic behavior. Its balanced polarity and aromatic content enable precise mechanistic studies.
CAT No: R2291
CAS No:1872435-02-3
Synonyms/Alias:MMP-13 Substrate;1872435-02-3;Dnp-Gly-Pro-Leu-Gly-Met-Arg-Gly-Leu-NH2 pound>>Dnp-GPLGMRGL-NH2 pound>>Matrix Metalloproteinase-13 Substrate pound>>MMP-13 Substrate;HY-P2414;DA-52644;PD077002;CS-0133766;(2S)-N-[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]-1-[2-(2,4-dinitroanilino)acetyl]pyrrolidine-2-carboxamide;Dnp-(Leu421)-Collagen Type VIII alpha1 Chain (419-426) amide (human, mouse) trifluoroacetate salt;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More